Abacus Wealth Partners’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
Abacus Wealth Partners's RDY Position: Q3 2026 in Review
Abacus Wealth Partners sold out of Dr. Reddy's Laboratories (RDY) in Q3 2026, closing a stake of 17,549 shares — an estimated $254K sold.
Abacus Wealth Partners first reported a position in RDY in Q4 2024 and held it in 5 quarters. The position peaked at $1.11M in Q4 2025. 236 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- Abacus Wealth Partners reported no remaining Dr. Reddy's Laboratories position as of Q3 2026 after selling out during the quarter.
- Abacus Wealth Partners sold 17,549 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $254K.
- Abacus Wealth Partners first reported a position in Dr. Reddy's Laboratories in Q4 2024 and held it in 5 quarters.
- Abacus Wealth Partners's Dr. Reddy's Laboratories position peaked at $1.11M in Q4 2025.
- 236 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on Abacus Wealth Partners's 13F filing for Q3 2026, filed 3 Nov 2026.